These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17177580)

  • 1. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
    Diener HC; Evers S
    Clin Drug Investig; 2007; 27(1):59-66. PubMed ID: 17177580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
    Spierings EL; Rapoport AM; Dodick DW; Charlesworth B
    CNS Drugs; 2004; 18(15):1133-41. PubMed ID: 15581383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    J Headache Pain; 2005 Oct; 6(5):405-11. PubMed ID: 16362714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolmitriptan nasal spray: advances in migraine treatment.
    Syrett N; Abu-Shakra S; Yates R
    Neurology; 2003 Oct; 61(8 Suppl 4):S27-30. PubMed ID: 14581655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany.
    Diener HC; Gendolla A
    Curr Med Res Opin; 2005; 21 Suppl 3():S18-24. PubMed ID: 16083520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of zolmitriptan nasal spray in adolescent migraine.
    Lewis DW; Winner P; Hershey AD; Wasiewski WW;
    Pediatrics; 2007 Aug; 120(2):390-6. PubMed ID: 17671066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
    McKeage K
    Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of new therapeutic deliveries in migraine.
    Dahlöf C
    Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myalgia and cramps associated with zolmitriptan.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2005; 28(5):241-2. PubMed ID: 16239765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ; Chen S; Reidenbach F; Rapoport AM
    Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.